IT - Software · Founded 2012 · www.ltts.com · BSE 540115 · NSE LTTS · ISIN INE010V01017
No Notes Added Yet
Business
L&T Technology Services Ltd. (LTTS) is a global pure-play engineering and R&D (ER&D) services company. It provides consulting, design, development, and testing services across the product and process development life cycle. The company helps global enterprises in their digital engineering transformation journeys by leveraging technologies like IoT, AI, 5G, and cybersecurity. LTTS's core business model involves partnering with clients to innovate, develop, and manage their engineering products and manufacturing processes. It makes money by charging for its specialized services, intellectual property, and engineering talent on project-based, time & material, or fixed-price contracts.
Revenue Mix
LTTS serves clients across a range of industry verticals. While exact percentages can fluctuate quarterly, its major segments typically include:
Transportation: Services for automotive (autonomous driving, electric vehicles), aerospace, and off-highway industries. (Often the largest segment)
Industrial Products: Engineering services for industrial machinery, building automation, and consumer electronics.
Plant Engineering: Solutions for process industries such as oil & gas, chemicals, and pharmaceuticals.
Medical Devices: R&D and engineering services for medical equipment and healthcare technology.
Telecom & Hi-Tech: Services for telecommunications equipment, semiconductors, and software product development.
These segments contribute significantly to its revenue, with Transportation, Industrial Products, and Plant Engineering often being the largest contributors.
Industry
LTTS operates within the global Engineering and R&D (ER&D) services industry, a specialized sub-segment of the broader IT services market. This industry is characterized by strong demand for niche engineering expertise, digital transformation capabilities, and domain-specific knowledge. LTTS is positioned as one of the leading pure-play ER&D service providers globally, distinct from generalist IT service firms. It competes with global engineering service providers, captives of large multinational corporations, and specialized niche players. Its affiliation with the Larsen & Toubro Group provides credibility and access to industrial expertise.
MOAT
LTTS's competitive advantages stem primarily from its:
Deep Domain Expertise & Specialization: As a pure-play ER&D company, it possesses specialized engineering talent and deep domain knowledge across multiple complex industries (e.g., aerospace, medical devices, automotive), which is difficult for generalist IT firms to replicate quickly.
Client Stickiness / Switching Costs: Engineering R&D projects often involve long engagement cycles, integration with client IP, and deep understanding of their product roadmaps. Switching providers can be costly, disruptive, and risky for clients due to potential knowledge transfer issues and project delays.
Parentage (L&T Group): Association with the engineering conglomerate Larsen & Toubro lends credibility, technological heritage, and understanding of industrial operations, which can be a differentiator.
Innovation & IP: Focus on creating intellectual property and platforms in niche areas further enhances its value proposition.
Growth Drivers
Key factors that can drive LTTS's growth over the next 3-5 years include:
Increased ER&D Outsourcing: Global enterprises are increasingly outsourcing their engineering R&D activities to gain efficiency, reduce costs, and access specialized talent.
Digital Engineering Transformation: Demand for digital transformation initiatives, including IoT, AI/ML, Industry 4.0, 5G, and cloud engineering, across all its verticals.
Emerging Technologies: Growth driven by investments in autonomous systems (vehicles, drones), connected products, sustainable engineering, and advanced manufacturing.
Industry-Specific Tailwinds: Demand for electric vehicles (EVs) in transportation, smart factory solutions in industrial products, and digital health in medical devices.
Expansion into New Geographies/Verticals: Strategic expansion to broaden its client base and service offerings.
Risks
Global Economic Slowdown: A downturn in key global economies can lead to reduced IT and ER&D spending by clients, impacting revenue and profitability.
Client Concentration: Dependency on a few large clients or specific industry verticals can expose the company to significant risk if those relationships sour or sectors face headwinds.
Intense Competition: The ER&D market is competitive, with players ranging from large global IT services firms to specialized niche providers, putting pressure on pricing and margins.
Talent Attrition & Cost: High demand for specialized engineering talent can lead to increased attrition rates and rising employee costs, affecting profitability.
Technological Disruption: Rapid technological changes require continuous investment in R&D and upskilling, failing to keep pace could erode competitive advantage.
Currency Fluctuations: Exposure to currency exchange rate volatility given its global client base and delivery model.
Management & Ownership
LTTS is promoted by the Larsen & Toubro (L&T) Group, one of India's largest and most respected conglomerates. L&T maintains a significant promoter shareholding, providing stability and strategic direction. The company is professionally managed with a clear organizational structure and experienced leadership team drawn from the technology and engineering sectors. Its management focuses on leveraging its engineering expertise, fostering innovation, and expanding its global footprint. Ownership structure includes the promoter group, institutional investors (domestic and foreign), and the public.
Outlook
LTTS is well-positioned to capitalize on the secular tailwinds driving the global engineering and R&D services market, particularly the accelerating digital transformation of industrial and technological sectors. Its pure-play focus and deep domain expertise give it an edge in securing complex, high-value contracts. However, the company faces inherent risks from global economic uncertainties, intense competition, and the constant need to adapt to evolving technologies and talent demands. Its ability to navigate these challenges while continuing to innovate and expand its service offerings will be crucial for sustained growth and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2422 | 2538 | 2462 | 2573 | 2653 | 2638 | 2866 | 2980 | 2924 | 2858 |
| Other Income | 62 | 56 | 62 | 65 | 34 | 49 | 68 | 66 | 33 | 55 |
| Total Income | 2484 | 2594 | 2524 | 2638 | 2687 | 2687 | 2934 | 3045 | 2957 | 2913 |
| Total Expenditure | 1934 | 2035 | 2006 | 2107 | 2158 | 2205 | 2404 | 2489 | 2410 | 2337 |
| Operating Profit | 550 | 559 | 518 | 531 | 528 | 482 | 530 | 556 | 547 | 577 |
| Interest | 13 | 13 | 13 | 12 | 16 | 16 | 17 | 16 | 15 | 17 |
| Depreciation | 72 | 75 | 73 | 78 | 73 | 81 | 81 | 93 | 87 | 87 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -35 | -37 |
| Profit Before Tax | 466 | 471 | 433 | 441 | 440 | 385 | 433 | 448 | 410 | 436 |
| Provision for Tax | 129 | 130 | 119 | 121 | 120 | 106 | 116 | 119 | 107 | 116 |
| Profit After Tax | 337 | 341 | 314 | 320 | 320 | 280 | 316 | 329 | 303 | 320 |
| Adjustments | -1 | -1 | -0 | -0 | 3 | 32 | -0 | -1 | -1 | 12 |
| Profit After Adjustments | 336 | 341 | 314 | 320 | 322 | 311 | 316 | 329 | 303 | 332 |
| Adjusted Earnings Per Share | 31.9 | 32.2 | 29.6 | 30.2 | 30.4 | 29.3 | 29.8 | 31 | 28.5 | 31.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3066 | 3248 | 3747 | 5078 | 5619 | 5450 | 6570 | 8816 | 9647 | 9642 | 10996 | 11628 |
| Other Income | 85 | 79 | 206 | 223 | 211 | 194 | 185 | 218 | 219 | 213 | 246 | 222 |
| Total Income | 3151 | 3328 | 3953 | 5301 | 5830 | 5644 | 6755 | 9033 | 9866 | 9855 | 11242 | 11849 |
| Total Expenditure | 2547 | 2684 | 3184 | 4164 | 4511 | 4483 | 5188 | 7069 | 7740 | 7856 | 9086 | 9640 |
| Operating Profit | 604 | 644 | 769 | 1138 | 1320 | 1161 | 1567 | 1964 | 2126 | 1999 | 2156 | 2210 |
| Interest | 3 | 2 | 2 | 2 | 37 | 46 | 44 | 44 | 51 | 57 | 64 | 65 |
| Depreciation | 59 | 63 | 89 | 104 | 183 | 218 | 214 | 234 | 272 | 303 | 345 | 348 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -72 | -72 |
| Profit Before Tax | 543 | 579 | 678 | 1031 | 1100 | 897 | 1309 | 1686 | 1804 | 1639 | 1675 | 1727 |
| Provision for Tax | 124 | 154 | 171 | 263 | 278 | 231 | 349 | 470 | 498 | 450 | 445 | 458 |
| Profit After Tax | 419 | 425 | 507 | 768 | 822 | 667 | 961 | 1216 | 1306 | 1190 | 1230 | 1268 |
| Adjustments | 1 | -0 | -1 | -3 | -4 | -3 | -4 | -4 | -3 | 77 | 49 | 10 |
| Profit After Adjustments | 419 | 425 | 506 | 766 | 819 | 663 | 957 | 1212 | 1304 | 1267 | 1279 | 1280 |
| Adjusted Earnings Per Share | 55.9 | 41.9 | 49.4 | 73.6 | 78.3 | 63.2 | 90.7 | 114.9 | 123 | 119.5 | 120.7 | 120.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 14% | 8% | 15% | 14% |
| Operating Profit CAGR | 8% | 3% | 13% | 14% |
| PAT CAGR | 3% | 0% | 13% | 11% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -26% | -6% | 3% | NA% |
| ROE Average | 20% | 23% | 24% | 39% |
| ROCE Average | 28% | 32% | 34% | 37% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1066 | 1486 | 1936 | 2479 | 2769 | 3473 | 4163 | 4435 | 5327 | 6080 | 6473 |
| Minority's Interest | -1 | -0 | 0 | 3 | 7 | 10 | 14 | 18 | 21 | 18 | 20 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -106 | -32 | -23 | 7 | 458 | 485 | 528 | 421 | 598 | 540 | 670 |
| Total Current Liabilities | 1010 | 747 | 764 | 863 | 1039 | 1098 | 1373 | 3310 | 2537 | 2990 | 2572 |
| Total Liabilities | 1969 | 2199 | 2678 | 3352 | 4272 | 5066 | 6077 | 8184 | 8483 | 9627 | 10398 |
| Fixed Assets | 621 | 614 | 709 | 780 | 1174 | 1282 | 1283 | 1303 | 1613 | 2245 | 2250 |
| Other Non-Current Assets | 51 | 146 | 108 | 200 | 189 | 281 | 469 | 504 | 640 | 918 | 782 |
| Total Current Assets | 1298 | 1440 | 1861 | 2372 | 2910 | 3503 | 4325 | 6377 | 6230 | 6464 | 6379 |
| Total Assets | 1969 | 2199 | 2678 | 3352 | 4272 | 5066 | 6077 | 8184 | 8483 | 9627 | 10398 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 115 | 83 | 71 | 152 | 203 | 213 | 178 | 237 | 527 | 1129 | 1382 |
| Cash Flow from Operating Activities | 528 | 388 | 409 | 806 | 638 | 1333 | 1006 | 1313 | 1493 | 1481 | 1455 |
| Cash Flow from Investing Activities | -176 | -178 | -196 | -509 | -222 | -1005 | -448 | -578 | -233 | -509 | -443 |
| Cash Flow from Financing Activities | -383 | -222 | -132 | -245 | -406 | -363 | -498 | -445 | -658 | -718 | -800 |
| Net Cash Inflow / Outflow | -32 | -12 | 81 | 52 | 10 | -36 | 60 | 290 | 602 | 254 | 213 |
| Closing Cash & Cash Equivalent | 83 | 71 | 152 | 203 | 213 | 178 | 237 | 527 | 1129 | 1383 | 1650 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 55.88 | 41.86 | 49.37 | 73.62 | 78.33 | 63.17 | 90.71 | 114.89 | 122.99 | 119.5 | 120.68 |
| CEPS(Rs) | 63.67 | 48.03 | 58.09 | 83.9 | 96.2 | 84.27 | 111.37 | 137.46 | 148.86 | 140.85 | 148.6 |
| DPS(Rs) | 1.51 | 7 | 16 | 21 | 21 | 22 | 35 | 45 | 50 | 55 | 58 |
| Book NAV/Share(Rs) | 42.15 | 143.31 | 183.67 | 235.07 | 261.55 | 327.94 | 392.78 | 411.48 | 493.49 | 564.93 | 604.87 |
| Core EBITDA Margin(%) | 16.94 | 17.38 | 15.02 | 18.01 | 19.73 | 17.74 | 21.04 | 19.81 | 19.77 | 18.53 | 17.37 |
| EBIT Margin(%) | 17.77 | 17.9 | 18.15 | 20.35 | 20.23 | 17.3 | 20.59 | 19.63 | 19.23 | 17.59 | 15.81 |
| Pre Tax Margin(%) | 17.69 | 17.83 | 18.09 | 20.31 | 19.58 | 16.47 | 19.93 | 19.13 | 18.7 | 17 | 15.23 |
| PAT Margin (%) | 13.65 | 13.08 | 13.52 | 15.13 | 14.64 | 12.23 | 14.62 | 13.8 | 13.54 | 12.34 | 11.19 |
| Cash Profit Margin (%) | 15.57 | 15.01 | 15.89 | 17.18 | 17.89 | 16.24 | 17.89 | 16.45 | 16.36 | 15.48 | 14.33 |
| ROA(%) | 22.34 | 20.39 | 20.77 | 25.49 | 21.57 | 14.27 | 17.24 | 17.06 | 15.68 | 13.14 | 12.28 |
| ROE(%) | 135.42 | 48 | 30.36 | 35.51 | 31.77 | 21.58 | 25.32 | 28.67 | 27.29 | 21.21 | 19.84 |
| ROCE(%) | 43.04 | 40.81 | 37.85 | 45.36 | 42.51 | 30.06 | 35.44 | 40.25 | 38 | 29.73 | 27.7 |
| Receivable days | 84 | 80.71 | 81.48 | 72.83 | 79.41 | 87.58 | 81.41 | 79.65 | 81.95 | 88.82 | 75.14 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0.09 | 0.14 | 0.16 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 18.69 | 25.11 | 21.34 | 14.84 | 42.03 | 56.25 | 29.39 | 44.56 | 37.66 | 25.85 |
| Price/Book(x) | 0 | 5.46 | 6.75 | 6.68 | 4.44 | 8.1 | 12.99 | 8.21 | 11.11 | 7.97 | 5.16 |
| Dividend Yield(%) | 0 | 0.89 | 1.29 | 1.34 | 1.81 | 0.83 | 0.69 | 1.33 | 0.91 | 1.22 | 1.86 |
| EV/Net Sales(x) | 0.38 | 2.46 | 3.37 | 3.19 | 2.12 | 5.07 | 8.09 | 3.96 | 5.88 | 4.79 | 2.86 |
| EV/Core EBITDA(x) | 1.92 | 12.39 | 16.41 | 14.25 | 9.04 | 23.81 | 33.91 | 17.78 | 26.67 | 23.08 | 14.57 |
| Net Sales Growth(%) | 17.09 | 5.94 | 15.36 | 35.53 | 10.65 | -3.01 | 20.55 | 34.18 | 9.44 | -0.05 | 14.04 |
| EBIT Growth(%) | 45.13 | 6.66 | 17.01 | 51.91 | 10.01 | -17.06 | 43.5 | 27.9 | 7.18 | -8.56 | 2.52 |
| PAT Growth(%) | 34.55 | 1.53 | 19.2 | 51.68 | 7.03 | -18.96 | 44.13 | 26.63 | 7.39 | -8.91 | 3.37 |
| EPS Growth(%) | 65.84 | -25.09 | 17.93 | 49.12 | 6.41 | -19.36 | 43.59 | 26.66 | 7.05 | -2.84 | 0.99 |
| Debt/Equity(x) | 0.18 | 0.07 | 0.04 | 0.03 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 1.29 | 1.93 | 2.44 | 2.75 | 2.8 | 3.19 | 3.15 | 1.93 | 2.46 | 2.16 | 2.48 |
| Quick Ratio(x) | 1.29 | 1.93 | 2.44 | 2.75 | 2.8 | 3.19 | 3.15 | 1.93 | 2.45 | 2.16 | 2.48 |
| Interest Cover(x) | 218 | 276.81 | 283.42 | 543.84 | 31.14 | 20.72 | 30.96 | 38.97 | 36.44 | 30.02 | 27.12 |
| Total Debt/Mcap(x) | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.75 | 73.74 | 73.69 | 73.69 | 73.66 | 73.66 | 73.59 | 73.58 | 73.58 | 73.57 |
| FII | 5.63 | 5.51 | 4.46 | 4.35 | 4.19 | 5.18 | 4.84 | 4.67 | 4.23 | 3.86 |
| DII | 11.33 | 12.09 | 13.07 | 13.73 | 14.06 | 13.68 | 13.87 | 14.13 | 14.57 | 14.64 |
| Public | 9.28 | 8.65 | 8.77 | 8.24 | 8.09 | 7.48 | 7.69 | 7.61 | 7.62 | 7.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
| FII | 0.6 | 0.58 | 0.47 | 0.46 | 0.44 | 0.55 | 0.51 | 0.5 | 0.45 | 0.41 |
| DII | 1.2 | 1.28 | 1.38 | 1.45 | 1.49 | 1.45 | 1.47 | 1.5 | 1.54 | 1.55 |
| Public | 0.98 | 0.91 | 0.93 | 0.87 | 0.86 | 0.79 | 0.82 | 0.81 | 0.81 | 0.84 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.57 | 10.58 | 10.58 | 10.58 | 10.59 | 10.59 | 10.6 | 10.6 | 10.6 | 10.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +14% | +8% | +15% | +14% |
| Operating Profit CAGR | +8% | +3% | +13% | +14% |
| PAT CAGR | +3% | 0% | +13% | +11% |
| Share Price CAGR | -26% | -6% | +3% | — |
| ROE Average | +20% | +23% | +24% | +39% |
| ROCE Average | +28% | +32% | +34% | +37% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.75 | 73.74 | 73.69 | 73.69 | 73.66 | 73.66 | 73.59 | 73.58 | 73.58 | 73.57 |
| FII | 5.63 | 5.51 | 4.46 | 4.35 | 4.19 | 5.18 | 4.84 | 4.67 | 4.23 | 3.86 |
| DII | 11.33 | 12.09 | 13.07 | 13.73 | 14.06 | 13.68 | 13.87 | 14.13 | 14.57 | 14.64 |
| Public | 26.25 | 26.26 | 26.31 | 26.31 | 26.34 | 26.34 | 26.41 | 26.42 | 26.42 | 26.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
| FII | 0.6 | 0.58 | 0.47 | 0.46 | 0.44 | 0.55 | 0.51 | 0.5 | 0.45 | 0.41 |
| DII | 1.2 | 1.28 | 1.38 | 1.45 | 1.49 | 1.45 | 1.47 | 1.5 | 1.54 | 1.55 |
| Public | 2.78 | 2.78 | 2.78 | 2.79 | 2.79 | 2.79 | 2.8 | 2.8 | 2.8 | 2.8 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.57 | 10.58 | 10.58 | 10.58 | 10.59 | 10.59 | 10.6 | 10.6 | 10.6 | 10.6 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.